Editas Medicine, Inc. EDIT
2.57 USD +0.02 (+0.78%)
At closeNov 6, 2026, 6:37 PM EST
2.57 0.00 0.00%
After hours · Nov 6, 6:37 PM ET
2.48 Day range 2.63
1.66 52-week range 3.75
- YTD
- +25.37%
- 1 year
- -4.46%
News
benzinga.com Wells Fargo Upgrades Editas Medicine to Overweight, Raises Price Target to $6 Wells Fargo analyst Yanan Zhu upgrades Editas Medicine (NASDAQ:EDIT) from Equal-Weight to Overweight and raises the price target from $4 to $6.
benzinga.com Editas Medicine Receives Approval To Initiate Its Phase 1/2 Strive Clinical Trial Of EDIT-401 In Patients With Heterozygous Familial Hypercholesterolemia In Australia The trial has received Human Research Ethics Committee (HREC) approval and completed the Clinical Trial Notification (CTN) process with Australia’s Therapeutic Goods Administration (TGA) and has also…